Morgan Stanley Neuro Sense Therapeutics Ltd. Call Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$86,6460.01% of portfolio
-
Xtx Topco LTD London, X046KShares$50,1350.0% of portfolio
-
Meitav Dash Investments LTD40KShares$43,6000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$37,3650.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$13,7610.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $12.7M